We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

224 hedge funds and large institutions have $2.54B invested in Sage Therapeutics in 2023 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 72 increasing their positions, 76 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

72% more first-time investments, than exits

New positions opened: 31 | Existing positions closed: 18

30% more call options, than puts

Call options by funds: $21.6M | Put options by funds: $16.6M

14% more capital invested

Capital invested by funds: $2.22B → $2.54B (+$321M)

6% more funds holding

Funds holding: 212 → 224 (+12)

1.99% more ownership

Funds ownership: 88.53% → 90.53% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less repeat investments, than reductions

Existing positions increased: 72 | Existing positions reduced: 76

Holders
224
Holders Change
+12
Holders Change %
+5.66%
% of All Funds
3.52%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
31
Increased
72
Reduced
76
Closed
18
Calls
$21.6M
Puts
$16.6M
Net Calls
+$4.98M
Net Calls Change
-$3.09M

Top Buyers

1
Fidelity Investments
Fidelity Investments
Massachusetts
+$84.9M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$32.3M
3
Lord, Abbett & Co
Lord, Abbett & Co
New Jersey
+$31.7M
4
PAMS
Pictet Asset Management (Switzerland)
Switzerland
+$29.5M
5
JP Morgan Chase
JP Morgan Chase
New York
+$15.8M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$41.2M
2
Marshall Wace
Marshall Wace
United Kingdom
-$30.5M
3
BlackRock
BlackRock
New York
-$25.2M
4
State Street
State Street
Massachusetts
-$21.7M
5
Goldman Sachs
Goldman Sachs
New York
-$21.6M
Name Holding Trade Value Shares
Change 		Change in
Stake
PFG
126
PAX Financial Group
Texas
$664K +$99.2K +1,993 +16%
CAM
127
ClariVest Asset Management
California
$662K -$139K -2,797 -17%
II
128
Inspire Investing
Idaho
$653K +$30.9K +622 +5%
Principal Financial Group
129
Principal Financial Group
Iowa
$646K -$34K -684 -5%
RJA
130
Raymond James & Associates
Florida
$632K +$185K +3,719 +38%
Envestnet Asset Management
131
Envestnet Asset Management
Illinois
$617K +$48K +964 +8%
DFCM
132
Dark Forest Capital Management
Puerto Rico
$608K +$485K +9,754 +307%
Group One Trading
133
Group One Trading
Illinois
$584K -$101K -2,029 -14%
HSA
134
Hussman Strategic Advisors
Maryland
$583K -$677K -13,600 -52%
TD Asset Management
135
TD Asset Management
Ontario, Canada
$568K -$1.81M -36,381 -75%
AQR Capital Management
136
AQR Capital Management
Connecticut
$523K -$118K -2,367 -18%
DTL
137
Dynamic Technology Lab
Singapore
$523K -$187K -3,756 -25%
CGL
138
Clarius Group LLC
Washington
$506K – – –
ProShare Advisors
139
ProShare Advisors
Maryland
$505K +$23.5K +472 +5%
NICM
140
Neo Ivy Capital Management
New York
$484K +$512K +10,290 New
Osaic Holdings
141
Osaic Holdings
Arizona
$463K -$175K -3,520 -26%
Handelsbanken Fonder
142
Handelsbanken Fonder
Sweden
$458K – – –
CI
143
Cavalier Investments
Georgia
$455K +$482K +9,679 New
FRM
144
Fox Run Management
Connecticut
$452K +$478K +9,606 New
PCM
145
Prelude Capital Management
New York
$424K -$248K -4,983 -36%
PI
146
PEAK6 Investments
Illinois
$423K +$238K +4,785 +114%
Public Employees Retirement Association of Colorado
147
Public Employees Retirement Association of Colorado
Colorado
$420K – – –
YIH
148
Y-Intercept (HK)
Hong Kong
$413K +$437K +8,774 New
RC
149
Roundview Capital
New Jersey
$388K – – –
CG
150
Cutler Group
California
$379K +$8.96K +180 +2%
4 5
6
7 8

SAGE Hedge Fund Activity: Q2 2023 in Review

224 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q2 2023, worth a combined $2.54B — up 14% from $2.22B a quarter earlier.

Buyers outnumbered sellers: 31 funds opened new SAGE positions and 18 closed out — a net gain of 13 holders — while 72 added to existing stakes and 76 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $84.9M. The largest seller was T. Rowe Price Associates, cutting an estimated $41.2M.

  • 224 institutional investors held Sage Therapeutics (SAGE) as of Q2 2023, up from 212 in Q1 2023.
  • Funds reported $2.54B of Sage Therapeutics stock for Q2 2023, up 14% quarter-over-quarter.
  • 31 funds opened new Sage Therapeutics positions in Q2 2023 and 18 closed out, a net change of +13 holders.
  • The largest Sage Therapeutics buyer in Q2 2023 was Fidelity Investments, an estimated $84.9M added.
  • The largest Sage Therapeutics seller in Q2 2023 was T. Rowe Price Associates, an estimated $41.2M sold.

Based on aggregated 13F filings for Q2 2023.